ELVN · Enliven Therapeutics, Inc.
SELL 96%
134
Total trades
14
Insiders on record
96%
Avg confidence
SELL
Signal direction
Recent insider trades
| Date | Insider | Action | Type | Value | Confidence |
|---|---|---|---|---|---|
| Apr 17, 2026 | Helen Louise Collins | SELL | Open-market sale | 117.3K | 0.74 |
| Apr 17, 2026 | Helen Louise Collins | SELL | Open-market sale | 6.4K | 0.66 |
| Apr 17, 2026 | Helen Louise Collins | SELL | Open-market sale | 114.6K | 0.74 |
| Mar 25, 2026 | Helen Louise Collins | SELL | Open-market sale | 1.4M | 1.00 |
| Mar 17, 2026 | Helen Louise Collins | SELL | Open-market sale | 138.8K | 1.00 |
| Mar 10, 2026 | Helen Louise Collins | SELL | Open-market sale | 305.8K | 1.00 |
| Mar 9, 2026 | Helen Louise Collins | SELL | Open-market sale | 896.8K | 1.00 |
| Mar 6, 2026 | Benjamin Hohl | SELL | Open-market sale | 295.8K | 1.00 |
| Feb 17, 2026 | Richard Heyman | SELL | Open-market sale | 32.2K | 0.87 |
| Feb 17, 2026 | Helen Louise Collins | SELL | Open-market sale | 1.2M | 1.00 |
Enliven Therapeutics, Inc. has 134 total insider trades on record. Sign up to see the full history, track records, and evidence trails.
Want alerts when insiders trade ELVN?
Sign up free to get notified, see the full trade history, and track insider conviction over time.
Sign up freeInsiderTrack aggregates publicly available SEC Form 4 filings. Data is provided for informational purposes only and should not be construed as investment advice. Always do your own research before making investment decisions.